Evidence map›Paper›PMID 42724814›Full record

ReviewClinical and experimental hepatology2026

Recommendations for treatment of viral hepatitis B in 2026 by the Polish Group of Experts for HBV.

Robert Flisiak, Jerzy Jaroszewicz, Piotr Małkowski, Małgorzata Pawłowska, Anna Piekarska, Maria Pokorska-Śpiewak, Krzysztof Simon, Krzysztof Tomasiewicz, Marta Wawrzynowicz-Syczewska, Dorota Zarębska-Michaluk

Abstract readReview
In one paragraph

Review in Clinical and experimental hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robert FlisiakDepartment of Infectious Diseases and Hepatology, Medical University of Białystok, Poland.
Jerzy JaroszewiczDepartment of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Poland.
Piotr MałkowskiDepartment of Surgical and Transplantation Nursing and Extracorporeal Therapies, Medical University of Warsaw, Poland.
Małgorzata PawłowskaDepartment of Infectious Diseases and Hepatology Collegium Medicum in Bydgoszcz Nicolaus Copernicus University, Toruń, Poland.
Anna PiekarskaDepartment of Infectious Diseases and Hepatology, Medical University of Łódź, Poland.
Maria Pokorska-ŚpiewakDepartment of Children's Infectious Diseases, Medical University of Warsaw, Poland.
Krzysztof SimonDepartment of Infectious Diseases and Hepatology, Wrocław Medical University, Poland.
Krzysztof TomasiewiczDepartment of Infectious Diseases and Hepatology, USK-1, Medical University of Lublin, Poland.
Marta Wawrzynowicz-SyczewskaDepartment of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University, Poland.
Dorota Zarębska-MichalukDepartment of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Polish Group of Experts (PGE) for hepatitis B virus (HBV), established by the Polish Society of Epidemiologists and Infectious Disease Physicians and the Polish Association for the Study of the Liver, published its first HBV management recommendations in 2007. The current recommendations have been expanded to include the prevention of HBV infection in various populations, the prevention of HBV reactivation, principles for monitoring treatment efficacy and safety, including early detection of hepatocellular carcinoma, and principles for safe treatment discontinuation and interruption. Recommendations for management of acute hepatitis B and co-infections with HDV, HCV, and HIV are also included. Consensus among the ten PGE HBV members was achieved using the Delphi method (5 survey rounds resolving 36 key issues; 2 discussion rounds to clarify doubts).

Indexed as

diagnosisHBVhepatocellular carcinomaliver cirrhosistreatment

Identifiers

PMID42724814
PMCPMC13559702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.